What Are You Looking For? SEARCH

Thursday, July 05, 2018

WHO Announces new drug to prevent excessive bleeding after childbirth


The World Health Organisation (WHO) in a new study has announced a new drug that can cure excessive bleeding after childbirth. It was in collaboration with MSD for Mothers and Ferring Pharmaceuticals.  The product innovator and oxytocin were provided by Novartis for the study.

The study, published on June 27, 2018, in the New England Journal of Medicine, has shown an alternative drug – heat-stable carbetocin – to be as safe and effective as oxytocin in preventing postpartum haemorrhage. This new formulation of carbetocin does not require refrigeration and retains its efficacy for at least 3 years stored at 30 degrees celsius and 75% relative humidity.

Commenting on the new drug, Dr Metin Gülmezoglu from the Department of Reproductive Health and Research at WHO states that:
“The development of a drug to prevent postpartum haemorrhage that continues to remain effective in hot and humid conditions is very good news for the millions of women who give birth in parts of the world without access to reliable refrigeration,”

Welcome development. 

No comments:

Post a comment

Reading your comments gives me joy. Keep them coming. Remember to share this post.

Note: The opinions expressed here are the personal opinions of readers and not that of Funmy Kemmy.

I could be reached by e-mail: funmykemmy2009@gmail.com. Catch Ya!